These findings were supported by studies in mice expressing human NOX5 in a podocyte‐specific manner that exhibited podocyte dysfunction, albuminuria and hypertension, processes that were exacerbated when mice were made diabetic by treatment with streptozotocin (Jha et al., 2017). The gene discussed is NOX5; the disease is Hypertension.